Clinical Genetics
From Bench to Bedside: CRISPR Gene Editing Enters the Era of Approved Medicine
Once confined to research laboratories, CRISPR-based therapies have crossed a historic threshold with FDA approvals that are reshaping what is possible for patients with previously untreatable genetic diseases. This milestone marks not just a scientific achievement, but a fundamental shift in how medicine addresses the root causes of inherited conditions. The journey from discovery to clinic, however, carries important questions about access, equity, and the long-term responsibilities of a socie
